ACCELERATE Pheno™

Every hour counts for patients with serious infections. Early, targeted antibiotic therapy is the most effective way to save lives and limit the adverse effects and costs of broad-spectrum, empiric treatments.MIC-based antimicrobial susceptibility testing (AST) is the one method used in microbiology that enables both escalation and de-escalation of treatment by demonstrating the resistance and susceptibility of an infection to antimicrobial agents.Conventional AST methods take days to produce results, leaving clinicians to rely on broad-spectrum therapy, often until final AST results are reported. Accelerate Diagnostics to provide fast phenotypic susceptibility results, often 1-2 days earlier than conventional methods.

Fast
Identification: < 90 minutes.
Antibiotic susceptibility (MIC): < 7 hours.

Fully Automated
2 minutes to load & start.
No culturing for isolates.
No manual McFarland prep.

Fully Automated
MIC-based susceptibilities.
SIR interpretations.
CLSI/EUCAST breakpoints.
Expert & Custom Rules.